KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Esperion Therapeutics (ESPR) Times Interest Earned (2019 - 2025)

Esperion Therapeutics (ESPR) has disclosed Times Interest Earned for 7 consecutive years, with $3.77 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Times Interest Earned rose 1498.98% year-over-year to $3.77, compared with a TTM value of $0.71 through Dec 2025, down 22.41%, and an annual FY2025 reading of $0.71, down 22.41% over the prior year.
  • Times Interest Earned was $3.77 for Q4 2025 at Esperion Therapeutics, up from -$0.45 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $5.15 in Q1 2024 and bottomed at -$10.19 in Q1 2021.
  • Average Times Interest Earned over 5 years is -$1.9, with a median of -$2.68 recorded in 2023.
  • Peak annual rise in Times Interest Earned hit 1498.98% in 2025, while the deepest fall reached 122.07% in 2025.
  • Year by year, Times Interest Earned stood at -$4.14 in 2021, then increased by 28.37% to -$2.97 in 2022, then grew by 5.16% to -$2.81 in 2023, then surged by 90.43% to -$0.27 in 2024, then skyrocketed by 1498.98% to $3.77 in 2025.
  • Business Quant data shows Times Interest Earned for ESPR at $3.77 in Q4 2025, -$0.45 in Q3 2025, and $0.35 in Q2 2025.